| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $257.6M | +4.2% |
| Cost of Revenue | $41.0M | -2.1% |
| R&D Expense | $135.2M | +5.7% |
| SG&A Expense | $62.4M | -32.3% |
| Operating Income | -$71.9M | +40.9% |
| Pre-tax Income | -$52.6M | +46.0% |
| Income Tax | $1.6M | +130.2% |
| Net Income | -$54.2M | +44.7% |
| EPS (Basic) | -$0.14 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $63.3M | +39.1% |
| Accounts Receivable | $34.4M | +10.3% |
| Current Assets | $448.2M | -4.0% |
| Total Assets | $486.8M | -5.3% |
| Current Liabilities | $31.9M | +14.3% |
| Total Liabilities | $55.5M | -8.2% |
| Stockholders' Equity | $431.3M | -4.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.5M | +132.0% |
| Capital Expenditures | $580K | +43.6% |
| Investing Cash Flow | $42.6M | -50.7% |
| Financing Cash Flow | -$34.0M | +58.1% |
| Free Cash Flow | $5.9M | +128.6% |
| +44.0% |
| EPS (Diluted) | -$0.14 | +44.0% |